Page last updated: 2024-08-21

diphenylamine and Central Nervous System Neoplasm

diphenylamine has been researched along with Central Nervous System Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Z; Diao, Y; Hou, J; Li, W; Wu, Y; Yang, Z; Zhang, L	1

Other Studies

1 other study(ies) available for diphenylamine and Central Nervous System Neoplasm

Article	Year
RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy. International journal of pharmaceutics, 2016, May-30, Volume: 505, Issue:1-2 Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Central Nervous System Neoplasms; Diphenylamine; Drug Delivery Systems; Drug Liberation; Drug Synergism; Female; Glioblastoma; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred BALB C; Oligopeptides; Xenograft Model Antitumor Assays	2016

Article

Year

RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy.

International journal of pharmaceutics, 2016, May-30, Volume: 505, Issue:1-2

Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Central Nervous System Neoplasms; Diphenylamine; Drug Delivery Systems; Drug Liberation; Drug Synergism; Female; Glioblastoma; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred BALB C; Oligopeptides; Xenograft Model Antitumor Assays

2016